-
(3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-Pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol
-
BD928932791-84-798%
-
登录
250mg
-
(R)-Cyclohex-3-enecarboxylic acid
-
BD470875709-98-898%
-
登录
10g
-
Mavrilimumab
-
BD016003741085337-57-098%
-
登录
-
Otilimab
-
BD018308071638332-55-495%
-
登录
-
Lenzilumab
-
BD015822281229575-09-098%
-
登录